MedaVance

We advance affordable market access to critical, complex injectable therapies and develop new formulations addressing adherence within chronic disease.

  • Stage Product In Development
  • Industry Biotechnology
  • Location New Providence, NJ, USA
  • Currency USD
  • Founded September 2018
  • Employees 3
  • Incorporation Type C-corp
  • Website medavance.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free